Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K023906
    Date Cleared
    2003-02-19

    (89 days)

    Product Code
    Regulation Number
    876.5320
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    PATHWAY CTS2000 PELVIC FLOOR TRAINING SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Indications for Use: Urinary Incontinence; Stress, Urge and Mixed Incontinence Neuromuscular Reeducation Fecal Incontinence; EMG USE ONLY

    Indications For Use

    • Urinary Incontinence: Stress, Urge and Mixed Incontinence
    • Neuromuscular Reeducation .
    • Fecal Incontinence: EMG USE ONLY
    Device Description

    The Pathway CTS2000 Pelvic Floor Training System provides electromyographic or pressure biofeedback from pelvic musculature as well as provides electrical stimulation capabilities for the purpose of rehabilitation of weak pelvic floor muscles and restoration of neuromuscular control for the treatment of urinary incontinence.

    The Pathway CTS 2000 uses Pathway Perineometer Sensors which are single-user sensors, and inserts the sensor into the vagina or rectum while using the Pathway CTS 2000 Pelvic Floor Training System to monitor the muscle activity during contraction and relaxation of the pelvic floor muscles. The patient can also use the Pathway CTS 2000 Pelvic Floor Training System to electrically stimulate the pelvic floor muscles to assist the contraction. The aim is to improve the strength and control of the pelvic floor muscles.

    The purpose of this premarket notification submission is to include additional electrical stimulation treatment frequencies of 100 and 200 Hz to the existing Pathway CTS2000 Pelvic Floor Therapy System, K001515.

    AI/ML Overview

    The provided text is a 510(k) Premarket Notification for the "Pathway CTS2000 Pelvic Floor Training System." This document focuses on demonstrating substantial equivalence to a predicate device rather than presenting a de novo study with acceptance criteria for device performance. Therefore, many of the requested elements (e.g., sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, training set details) are not applicable or extractable from this type of regulatory submission.

    The submission primarily compares the technical characteristics of the new device with existing predicate devices to show it is as safe and effective.

    Here's an analysis based on the information available:

    1. Table of Acceptance Criteria and Reported Device Performance

    There are no explicit "acceptance criteria" for device performance in the traditional sense (e.g., clinical trial endpoints with predefined thresholds). Instead, the device is deemed acceptable if its technical characteristics are substantially equivalent to the predicate devices. The "reported device performance" is a comparison of these technical characteristics.

    CharacteristicAcceptance Criteria (Predicate Device K001515)Proposed Device Performance (Pathway CTS2000)
    Intended UseTreatment of Urinary IncontinenceTreatment of Urinary Incontinence
    Stimulator Output0-100 mA0-100 mA
    WaveformAsymmetrical Balanced Pulsed CurrentAsymmetrical Balanced Pulsed Current
    Charge/pulse at 500 ohms28uC28uC
    Frequency12.5, 50 Hz12.5, 50, 100, 200 Hz (This is the primary change seeking approval)
    Peak pulse intensity100 mA100 mA
    Pulse width.3 ms fixed.3 ms fixed
    Ramps2 sec on ramp, one sec off ramp2 sec on ramp, one sec off ramp
    Duty CycleOn (sec): 1-80, Off (sec): 0-80On (sec): 1-80, Off (sec): 0-80
    Session Duration (min)0-300-30
    Programmable featuresNone by Patient; Frequency, Duty cycle, Session Length by physicianNone by Patient; Frequency, Duty cycle, Session Length by physician
    Vaginal EMG/Stim Probe UsedPathway Vaginal EMG/Stimulation Sensor K993976Pathway Vaginal EMG/Stimulation Sensor K993976
    Anal EMG/Stim Probe UsedPathway Anal EMG/Stimulation Sensor K993976Pathway Anal EMG/Stimulation Sensor K993976
    Vaginal EMG/Stim probe electrode surface area2.31 cm²2.31 cm²
    Anal EMG/Stim probe Electrode surface area2.12 cm²2.12 cm²
    Current Density (full output)Pathway Vaginal EMG/Stim Sensor: .043 A/cm²
    Pathway Anal EMG/Stim Sensor: .047 A/cm² (Max. Instantaneous)Pathway Vaginal EMG/Stim Sensor: .043 A/cm²
    Pathway Anal EMG/Stim Sensor: .047 A/cm² (Max. Instantaneous)
    Power Density (full output @ 500 ohms)Pathway Vaginal EMG/Stim Sensor: .487 mW/cm²
    Pathway Anal EMG/Stim Sensor: .531 mW/cm² (.3mS pulse, 50Hz)Pathway Vaginal EMG/Stim Sensor: 7.79 mW/cm²
    Pathway Anal EMG/Stim Sensor: 8.49 mW/cm² (.3mS pulse, 200Hz)
    EMG Ranges0-5, 0-30, 0-100, 0-1000 uV Ranges0-5, 0-30, 0-100, 0-1000 uV Ranges
    EMG Bandwidth20-500Hz20-500Hz
    EMG Signal ProcessingRoot Mean Square (RMS)Root Mean Square (RMS)
    EMG DetectionBipolarBipolar
    Vaginal Pressure Probe UsedPathway Vaginal Pressure Sensor manufactured by DesChutes Medical K934552Pathway Vaginal Pressure Sensor manufactured by DesChutes Medical K934552
    Anal Pressure Probe UsedPathway Anal Pressure Sensor manufactured by DesChutes Medical K934552Pathway Anal Pressure Sensor manufactured by DesChutes Medical K934552
    Work Period (sec)1-80 seconds1-80 seconds
    Rest Period (sec)0-80 seconds0-80 seconds

    2. Sample size used for the test set and the data provenance

    • Sample Size: Not applicable. This submission relies on technical comparisons and bench testing rather than a clinical human test set.
    • Data Provenance: The data is from laboratory (bench) tests conducted by The Prometheus Group, likely within the United States. It is retrospective in the sense that it evaluates the modified device against existing and approved predicate devices.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. No human experts were used to establish ground truth for a test set in this 510(k) submission. Equivalency is based on objective technical specifications and bench testing.

    4. Adjudication method for the test set

    Not applicable. There was no test set requiring human adjudication.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is not an AI-enabled device, and no MRMC study was conducted.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is not an algorithm-only device. The assessment is of the physical and electrical characteristics of the device. Bench tests were performed on the device itself.

    7. The type of ground truth used

    The "ground truth" for demonstrating substantial equivalence is based on:

    • Technical Specifications: Direct comparison of electrical and physical parameters (e.g., output current, frequency, pulse width, electrode surface area) against predicate devices.
    • Bench Test Results: Laboratory testing for electrical safety and performance (e.g., current density, power density) and biocompatibility of sensor materials, all aligned with recognized standards.

    8. The sample size for the training set

    Not applicable. This is not a machine learning or AI device that requires a training set.

    9. How the ground truth for the training set was established

    Not applicable. See point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1